Chene Gardner
Director of Finance/CFO at FUELSTREAM, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Darrow Thomas | M | 47 | 12 years | |
| Kenneth Denos | M | 56 |
Synerteck, Inc.
| 25 years |
| Joseph Darold Caywood | M | 49 | - | |
| Ian Jenkins | M | 40 | 7 years | |
| David Baum | M | - | 8 years | |
| Sean Martin | M | - | 8 years | |
| Erwin Vahlsing | M | 67 | - | |
| David Kugelman | M | - | - | |
| Kevin Blanco | M | - | 12 years | |
| Kyle M. Denos | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Daniel Klok | M | 48 | 8 years | |
| Juan-Carlos Ley | M | 53 | - | |
| Scott Weissman | M | 46 | 1 years | |
| Lee R. Rice | M | 80 | 2 years | |
| Jim E. Frazier | M | 59 | - | |
| Thomas McConnell | M | 61 | 2 years | |
| Russell Bruce Adler | M | 63 | 1 years | |
| Maryorie Michelle Rivas Batista | M | - | - | |
| Norris R. Harris | M | 90 | - | |
| Ralph Robert Catala | M | 65 | - | |
| David Zimmerman | M | - | - | |
| Lorne Kalisky | M | 54 | - | |
| Corey Safran | M | 55 | - | |
| George J. Edwards | M | 76 | 2 years | |
| Whit Tehan | M | - | - | |
| Clayton B. Barlow | M | 52 |
Cancer Therapeutics, Inc.
 Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT.
Synerteck, Inc.
| 6 years |
| Douglas McFarland | M | 80 | - | |
| Joseph Toro | M | 38 | 1 years | |
| Paul Douglas Major | M | 71 | 1 years | |
| Randall S. Appel | M | - | - | |
| Cyrus J. Boga | M | 56 | 3 years | |
| Stephen Arne D. Greaves | M | 59 | - | |
| Ruben Flores | M | 46 | 3 years | |
| Jackie Stephens | M | 58 | - | |
| David J. Kovacs | M | 38 | - | |
| Scott Bouslog | M | 62 | 1 years | |
| Walter Pera | M | 79 | 8 years | |
| Paul R. Donaldson | M | 79 | - | |
| David Zirulnikoff | M | 49 | - | |
| John D. Thomas | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
| Kristina Hammonds | F | - | - | |
| Sean E. Wagner | M | 51 | - | |
| Robert K. Oldham | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
| Michael K. Low | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
| Mirta Mojica de Quintero | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 45 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Chene Gardner
- Personal Network
